A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo ; volume:9 ; number:6 ; day:31 ; month:5 ; year:2018 ; pages:1-10 ; date:6.2018
Cell death & disease ; 9, Heft 6 (31.5.2018), 1-10, 6.2018
- Creator
-
Zou, Jianling
- Contributor
-
Li, Shuang
Chen, Zuhua
Lu, Zhihao
Gao, Jing
Zou, Jianyin
Lin, Xiaoting
Li, Yanyan
Zhang, Cheng
Shen, Lin
SpringerLink (Online service)
- DOI
-
10.1038/s41419-018-0700-0
- URN
-
urn:nbn:de:101:1-2018080723184379278217
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zou, Jianling
- Li, Shuang
- Chen, Zuhua
- Lu, Zhihao
- Gao, Jing
- Zou, Jianyin
- Lin, Xiaoting
- Li, Yanyan
- Zhang, Cheng
- Shen, Lin
- SpringerLink (Online service)
Other Objects (12)
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
Homogeneous axisymmetric solutions of incompressible stationary Navier-Stokes equations and vanishing viscosity limit
Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
Homogeneous axisymmetric solutions of incompressible stationary Navier-Stokes equations and vanishing viscosity limit
Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
Homogeneous axisymmetric solutions of incompressible stationary Navier-Stokes equations and vanishing viscosity limit
Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer